Foreal Spectrum

Biotechnology

United States, California

$10M to $25M

51-200

Vigene Biosciences, A Charles River Company

Biotechnology

United States, Maryland

$10M to $25M

51-200

Indication BioScience

Biotechnology

United States, Colorado

$10M to $25M

51-200

Microgenics

Biotechnology

United States, California

$10M to $25M

51-200

Genelabs Technologies

Biotechnology

United States, Texas

$10M to $25M

51-200

1859

Biotechnology

United States, California

$10M to $25M

51-200

ChemGenes

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

SillaJen

Biotechnology

United States, California

$10M to $25M

51-200

University of Hawai'i Cancer Center

Biotechnology

United States, Hawaii

$10M to $25M

51-200

Gates Biomanufacturing Facility

Biotechnology

United States, Colorado

$10M to $25M

51-200

TCR² Therapeutics

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Infinant Health

Biotechnology

United States, California

$10M to $25M

51-200

Socati

Biotechnology

United States, Texas

$10M to $25M

51-200

Thrive, An Exact Sciences Company

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Florida Biologix

Biotechnology

United States, Florida

$10M to $25M

51-200

Regener-Eyes®

Biotechnology

United States, Florida

$10M to $25M

51-200

MOLECULAR EPIDEMIOLOGY

Biotechnology

United States, Washington

$10M to $25M

51-200

Prevail Therapeutics

Biotechnology

United States, New York

$10M to $25M

51-200

Lentigen Technology

Biotechnology

United States, Maryland

$10M to $25M

51-200

Vernal Biosciences

Biotechnology

United States, Vermont

$10M to $25M

51-200